Abstract
Background
Sympathetic ophthalmia (SO) is an uncommon uveitic condition that occurs after injury to the uvea of one eye and may occur after accidental ocular trauma or ocular surgery. We sought to investigate the common causes of SO in Singapore and the demographic profile as well as the final visual acuity after treatment in these patients.
Methods
This was a retrospective, non-comparative case series in which patients with SO were identified from the Singapore National Eye Centre uveitis database in the period between 1993 and 2003. The patients' case records were examined for a history of ocular trauma or surgery and subsequent development of bilateral or contralateral uveitis consistent with SO or histopathological evidence of SO in enucleated eyes. The medical records of these patients were reviewed for details of the inciting event, presentation, treatment, and visual acuity.
Results
A total of ten patients (six men and four women) were diagnosed with SO in the period of study. SO occurred after accidental trauma in three patients and following ocular surgery in seven. Vitreoretinal surgery was responsible for four of these cases, and diode laser cyclophotoablation for another two, whereas neodymium:yttrium–aluminium–garnet (Nd:YAG) laser cyclotherapy was the cause in the last patient. Overall, six of ten patients underwent at least one vitreoretinal procedure. Four of the patients had a final visual acuity of 6/15 or better, whereas five had a visual acuity of 6/30 or worse. Good final visual acuity appeared to be associated with early initiation of immunosuppressive therapy.
Conclusion
In this series, ocular surgery, especially vitreoretinal surgery, had overtaken non-surgical trauma as the major cause of SO. A good outcome was possible in most cases if an early diagnosis was made and immunosuppressive treatment started promptly.
Similar content being viewed by others
References
Bechrakis NE, Muller-Stolzenburg NW, Helbig H, Foerster MH (1994) Sympathetic ophthalmia following laser cyclocoagulation. Arch Ophthalmol 112:80–84
Bernasioni O, Auer C, Zografos L, Herbort CP (1998) Indocyanine green angiographic findings in sympathetic ophthalmia. Graefe Arch Clin Exp Ophthalmol 236:635–638
Boyd SR, Young S, Lightman S (2001) Immunopathology of the noninfectious posterior and intermediate uveitides. Surv Ophthalmol 46:209–233
Brancato R, Carassa RG, Bettin P, Fiori M, Trabucchi G (1995) Contact laser transscleral cyclophotocoagulation with diode laser in refractory glaucoma. Eur J Ophthalmol 5:32–39
Chan CC, Roberge FG, Whitcup SM, Nussenblatt RB (1995) 32 Cases of sympathetic ophthalmia. A retrospective study at the National Eye Institute, Bethesda, Md, from 1982 to 1992. Arch Ophthalmol 113:597–600
Chu DS, Foster CS (2002) Sympathetic ophthalmia. Int Ophthalmol Clin 42:179–185
Easom HA, Zimmerman LE (1964) Sympathetic ophthalmia and bilateral phacoanaphylaxis. A clinicopathological correlation of the sympathogenic and sympathizing eyes. Arch Ophthalmol 72:9–15
Gasch AT, Foster CS, Grosskreutz CL, Pasquale LR (2000) Postoperative sympathetic ophthalmia. Int Ophthalmol Clin 40:69–84
Goto H, Rao NA (1990) Sympathetic ophthalmia and Vogt–Koyanagi–Harada's syndrome. Int Ophthalmol Clin 30:280–285
Hakin KN, Pearson RV, Lightman SL (1992) Sympathetic ophthalmia: visual results with modern immunosuppressive therapy. Eye 6:453–455
Jennings T, Tessler HH (1989) Twenty cases of sympathetic ophthalmia. Br J Ophthalmol 73:140–145
Jonas JB, Holbach LM, Schonherr U, Naumann GOH (2000) Sympathetic ophthalmia after three pars plana vitrectomies without prior ocular injury. Retina 20:405–406
Jonas JB, Kreissig I, Sofker A, Degenring RF (2003) Intravitreal injection of triamcinolone acetonide for diffuse diabetic macular edema. Arch Ophthalmol 121:57–61
Kilmartin DJ, Dick AD, Forrester JV (2000) Prospective surveillance of sympathetic ophthalmia in the UK and Republic of Ireland. Br J Ophthalmol 84:259–263
Kumar N, Chang A, Beaumont P (2004) Sympathetic ophthalmia following ciliary body laser cyclophotocoagulation for rubeotic glaucoma. Clin Exp Ophthalmol 32:196–198
Lam S, Tessler HH, Lam BL, Wilensky JT (1992) High incidence of sympathetic ophthalmia after contact and non-contact neodymium:YAG cyclotherapy. Ophthalmology 99:1818–1822
Liddy BSTL, Stuart J (1972) Sympathetic ophthalmia in Canada. Can J Ophthalmol 7:157–159
McKelvie PA, Walland MJ (2002) Pathology of cyclodiode laser: a series of nine enucleated eyes. Br J Ophthalmol 86:381–386
Pollack AL, McDonald HR, Ai E, Green WR, Halpern LS, Jampol LM, Leahy JM, Johnson RN, Spencer WH, Stern WH, Weinberg DV, Werner JC, Williams GA (2001) Sympathetic ophthalmia associated with pars plana vitrectomy without antecedent trauma. Retina 21:146–154
Ranson NT, Danis RP, Ciulla TA, Pratt L (2002) Intravitreal triamcinolone in subfoveal recurrence of choroidal neovascularisation after laser treatment in macular degeneration. Br J Ophthalmol 86:527–529
Rao NA (1997) Mechanisms of inflammatory response in sympathetic ophthalmia and VKH syndrome. Eye 11:213–216
Sharp DC, Bell RA, Patterson E, Pinkerton RM (1984) Sympathetic ophthalmia—histopathologic and fluorescein angiographic correlation. Arch Ophthalmol 102:232–235
The Eyetech Study Group (2003) Anti-vascular endothelial growth factor therapy for subfoveal choroidal neovascularization secondary to age-related macular degeneration. Phase II study results. Ophthalmology 110:979–986
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Su, D.HW., Chee, SP. Sympathetic ophthalmia in Singapore: new trends in an old disease. Graefe's Arch Clin Exp Ophthalmo 244, 243–247 (2006). https://doi.org/10.1007/s00417-005-0009-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-005-0009-4